Bieber, Thomas, Lisa Beck, Andrew Pink, Hidehisa Saeki, Lawrence Eichenfeld, Thomas Werfel, Anders Rosholm, Mads Ropke, and Amy Paller. “Neutralizing Interleukin-13 Increases Skin Microbial Diversity: Results from a Phase 3, Randomized, Double-Blind, Placebo-Controlled Trial of Tralokinumab in Adult Patients With Atopic Dermatitis”. SKIN The Journal of Cutaneous Medicine 5, no. 6 (November 5, 2021): s56. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/1407.